LAGOSTA is a Swiss blue biotech company expert in biomedical chitosan production. LAGOSTA farms European spiny lobsters, who during their growth naturally generate molts, who once harvested are converted in chitosan with unparalleled molecular characteristics for biomedical applications.
Products, services, technology
LAGOSTA, thanks to this innovative approach, is the sole company to offer a biomedical chitosan with reproducible biological properties, high molecular weight, high degree of deacetylation as well as EU and US pharmacopoeia compliance.
If you are seeking reproducible biomedical chitosan with stable biological and physicochemical characteristics from batch to batch to move your programs forward and unlock chitosan’s biomedical potential, offering new treatments to patients worldwide. We look forward to collaborating with you.